BR0009016A - Composição de apomorfina e sildenafil - Google Patents
Composição de apomorfina e sildenafilInfo
- Publication number
- BR0009016A BR0009016A BR0009016-6A BR0009016A BR0009016A BR 0009016 A BR0009016 A BR 0009016A BR 0009016 A BR0009016 A BR 0009016A BR 0009016 A BR0009016 A BR 0009016A
- Authority
- BR
- Brazil
- Prior art keywords
- sildenafil
- apomorphine
- administered
- composition
- treatment
- Prior art date
Links
- BNRNXUUZRGQAQC-UHFFFAOYSA-N sildenafil Chemical compound CCCC1=NN(C)C(C(N2)=O)=C1N=C2C(C(=CC=1)OCC)=CC=1S(=O)(=O)N1CCN(C)CC1 BNRNXUUZRGQAQC-UHFFFAOYSA-N 0.000 title abstract 10
- 229960003310 sildenafil Drugs 0.000 title abstract 5
- 229960004046 apomorphine Drugs 0.000 title abstract 4
- VMWNQDUVQKEIOC-CYBMUJFWSA-N apomorphine Chemical group C([C@H]1N(C)CC2)C3=CC=C(O)C(O)=C3C3=C1C2=CC=C3 VMWNQDUVQKEIOC-CYBMUJFWSA-N 0.000 title abstract 4
- 201000001880 Sexual dysfunction Diseases 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000001257 erectogenic effect Effects 0.000 abstract 1
- 231100000872 sexual dysfunction Toxicity 0.000 abstract 1
- 230000001568 sexual effect Effects 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Gynecology & Obstetrics (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
"COMPOSIçãO DE APOMORFINA E SILDENAFIL". Tratamento de disfunção sexual em pacientes humanos através de um regime de terapia oral de administração de apomorfina e sildenafil é disposto. Esse tratamento otimiza a eficácia de cada droga e substancialmente minimiza os efeitos colaterais indesejáveis associados a eles individualmente. A apomorfina e o sildenafil podem ser co-administrados com uma unidade de dosagem de combinação ou administrada seq³encialmente em unidades de dosagem separadas, substancialmente antes da atividade sexual. Outro agente eretogênico pode ser administrado com apomorfina e sildenafil.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/270,035 US6087362A (en) | 1999-03-16 | 1999-03-16 | Apomorphine and sildenafil composition |
PCT/US2000/006654 WO2000054774A1 (en) | 1999-03-16 | 2000-03-14 | Apomorphine and sildenafil composition |
Publications (1)
Publication Number | Publication Date |
---|---|
BR0009016A true BR0009016A (pt) | 2002-04-16 |
Family
ID=23029614
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR0009016-6A BR0009016A (pt) | 1999-03-16 | 2000-03-14 | Composição de apomorfina e sildenafil |
Country Status (21)
Country | Link |
---|---|
US (1) | US6087362A (pt) |
EP (1) | EP1173178B1 (pt) |
JP (1) | JP2002539163A (pt) |
CN (1) | CN1350454A (pt) |
AT (1) | ATE302003T1 (pt) |
AU (1) | AU3744500A (pt) |
BR (1) | BR0009016A (pt) |
CA (1) | CA2367605A1 (pt) |
CZ (1) | CZ20013344A3 (pt) |
DE (1) | DE60022021T2 (pt) |
DK (1) | DK1173178T3 (pt) |
ES (1) | ES2244418T3 (pt) |
HU (1) | HUP0200549A3 (pt) |
IL (1) | IL145487A0 (pt) |
MX (1) | MXPA01009332A (pt) |
NO (1) | NO324511B1 (pt) |
NZ (1) | NZ514464A (pt) |
PL (1) | PL350313A1 (pt) |
PT (1) | PT1173178E (pt) |
WO (1) | WO2000054774A1 (pt) |
ZA (1) | ZA200107920B (pt) |
Families Citing this family (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20040063719A1 (en) * | 1998-08-26 | 2004-04-01 | Queen's University At Kingston | Combination therapy using antihypertensive agents and endothelin antagonists |
US6428769B1 (en) * | 1999-05-04 | 2002-08-06 | Aradigm Corporation | Acute testosterone administration |
US20020013327A1 (en) * | 2000-04-18 | 2002-01-31 | Lee Andrew G. | Compositions and methods for treating female sexual dysfunction |
KR100861603B1 (ko) * | 2000-08-30 | 2008-10-07 | 유니메드 파마슈티칼스, 엘엘씨 | 발기부전의 치료 및 남성의 리비도를 증가시키는 방법 |
US20030139384A1 (en) * | 2000-08-30 | 2003-07-24 | Dudley Robert E. | Method for treating erectile dysfunction and increasing libido in men |
US6503894B1 (en) | 2000-08-30 | 2003-01-07 | Unimed Pharmaceuticals, Inc. | Pharmaceutical composition and method for treating hypogonadism |
US6821978B2 (en) | 2000-09-19 | 2004-11-23 | Schering Corporation | Xanthine phosphodiesterase V inhibitors |
US20020091129A1 (en) * | 2000-11-20 | 2002-07-11 | Mitradev Boolell | Treatment of premature ejaculation |
JP2004520389A (ja) * | 2001-02-08 | 2004-07-08 | ファルマシア・コーポレーション | 性的不全の治療のための早期効果発現薬剤 |
ES2180446B1 (es) * | 2001-07-02 | 2004-01-16 | Esteve Labor Dr | Empleo de derivados de acidos 2,5-dihidroxibencenosulfonicos en la elaboracion de un medicamento para potenciar el efecto de otros farmacos en el tratamiento de la disfuncion erectil. |
US20030044458A1 (en) * | 2001-08-06 | 2003-03-06 | Curtis Wright | Oral dosage form comprising a therapeutic agent and an adverse-effect agent |
EP1421084B1 (en) * | 2001-08-28 | 2008-05-14 | Schering Corporation | Polycyclic guanine phosphodiesterase v inhibitors |
US20030114469A1 (en) * | 2001-09-27 | 2003-06-19 | Cohen David Saul | Combinations |
US20030216407A1 (en) * | 2002-01-31 | 2003-11-20 | Pfizer Inc. | Use of PDE5 inhibitors in the treatment of scarring |
CN1720054A (zh) * | 2002-03-19 | 2006-01-11 | 布雷恩及比扬德生物科技公司 | 阿朴吗啡和其类似物的糖苷和原酸酯糖苷衍生物及其用途 |
US8821915B2 (en) | 2002-08-09 | 2014-09-02 | Veroscience, Llc | Therapeutic process for the treatment of the metabolic syndrome and associated metabolic disorders |
US7037257B1 (en) * | 2002-08-22 | 2006-05-02 | Koenig J Frank | Erectile dysfuction treatments comprising momentary vacuum therapy alone or with medications |
TWI330529B (en) * | 2003-01-13 | 2010-09-21 | Horphag Res Luxembourg Holding Sa | A preparation for improving sperm quality or fertility,a kit comprising the same and uses thereof |
GB0304636D0 (en) * | 2003-02-28 | 2003-04-02 | Britannia Pharmaceuticals Ltd | Pharmaceutical composition for nasal delivery |
US7276246B2 (en) * | 2003-05-09 | 2007-10-02 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
US7306812B2 (en) * | 2003-05-09 | 2007-12-11 | Cephalon, Inc. | Dissolvable backing layer for use with a transmucosal delivery device |
DE10325813B4 (de) * | 2003-06-06 | 2007-12-20 | Universitätsklinikum Freiburg | Prophylaxe und/oder Therapie bei der portalen Hypertonie |
CN102512681A (zh) * | 2004-05-11 | 2012-06-27 | 情感智能有限责任公司 | 药物制剂及其在治疗女性性功能障碍中的应用 |
WO2006042409A1 (en) * | 2004-10-20 | 2006-04-27 | Endorecherche, Inc. | Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cgmp phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women |
PL2450041T3 (pl) | 2005-10-12 | 2019-02-28 | Unimed Pharmaceuticals, Llc | Ulepszony żel zawierający testosteron do zastosowania do leczenia hipogonadyzmu |
PL2114147T3 (pl) * | 2007-02-12 | 2012-10-31 | Vyrix Pharmaceuticals Inc | Zmniejszanie skutków ubocznych tramadolu |
AU2008216356C1 (en) * | 2007-02-12 | 2014-07-24 | Aytu Bioscience, Inc. | Treatment of comorbid premature ejaculation and erectile dysfunction |
US20100035886A1 (en) | 2007-06-21 | 2010-02-11 | Veroscience, Llc | Parenteral formulations of dopamine agonists |
US8741918B2 (en) * | 2007-06-21 | 2014-06-03 | Veroscience Llc | Parenteral formulations of dopamine agonists |
GB0715285D0 (en) * | 2007-08-06 | 2007-09-12 | Britannia Pharmaceuticals Ltd | Improvements in or relating to powdered medicaments for nasal delivery |
US8268806B2 (en) | 2007-08-10 | 2012-09-18 | Endorecherche, Inc. | Pharmaceutical compositions |
KR20100097753A (ko) * | 2007-12-26 | 2010-09-03 | 바이오테스트 아게 | Cd138 표적성 면역접합체 및 이의 용도 |
JP2011508738A (ja) * | 2007-12-26 | 2011-03-17 | バイオテスト・アクチエンゲゼルシヤフト | Cd138発現腫瘍細胞のターゲティングを向上させる方法及び剤 |
US9011864B2 (en) * | 2007-12-26 | 2015-04-21 | Biotest Ag | Method of decreasing cytotoxic side-effects and improving efficacy of immunoconjugates |
MX341344B (es) * | 2007-12-26 | 2016-08-16 | Biotest Ag | Agentes dirigidos a cd138 y sus usos. |
US20090246298A1 (en) * | 2008-03-31 | 2009-10-01 | Ceola P. Steele | Viagra |
US20100184722A1 (en) * | 2008-12-19 | 2010-07-22 | Shimoda Biotech (Pty) Ltd | Inclusion complexes of alpha-cyclodextrin and sildenafil salt |
SG10201401976YA (en) * | 2009-05-06 | 2014-10-30 | Biotest Ag | Uses of immunoconjugates targeting cd138 |
US9352025B2 (en) | 2009-06-05 | 2016-05-31 | Veroscience Llc | Combination of dopamine agonists plus first phase insulin secretagogues for the treatment of metabolic disorders |
DK2442650T3 (en) | 2009-06-12 | 2015-12-07 | Cynapsus Therapeutics Inc | sublingual apomorphine |
WO2012000634A1 (de) | 2010-06-29 | 2012-01-05 | Georg Bambach | Pharmazeutische zusammensetzung zur behandlung von erektiler dysfunktion |
TWI462739B (zh) | 2010-11-02 | 2014-12-01 | Univ Kaohsiung Medical | Sildenafil-同族物四級銨哌嗪鹽類之製備及醫療用途 |
NZ612686A (en) | 2010-12-16 | 2015-11-27 | Cynapsus Therapeutics Inc | Sublingual films |
BR112014013694A2 (pt) | 2011-12-08 | 2017-06-13 | Biotest Ag | método para tratar uma doença, e, kit |
JP7211706B2 (ja) | 2015-04-21 | 2023-01-24 | サノヴィオン ファーマシュティカルズ インコーポレーテッド | 口腔粘膜へのアポモルフィンの投与によるパーキンソン病の治療方法 |
WO2017168174A1 (en) | 2016-04-02 | 2017-10-05 | N4 Pharma Uk Limited | New pharmaceutical forms of sildenafil |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5256652A (en) * | 1987-11-12 | 1993-10-26 | Pharmedic Co. | Topical compositions and methods for treatment of male impotence |
DE69534693T2 (de) * | 1994-04-22 | 2006-08-31 | Pentech Pharmaceuticals, Inc., Wheeling | Sublinguale Zusammensetzung enthaltend Apomorphine zur Diagnose der funktionellen Impotenz |
GB9612514D0 (en) * | 1996-06-14 | 1996-08-14 | Pfizer Ltd | Novel process |
PT996447E (pt) * | 1997-05-19 | 2006-12-29 | Zonagen Inc | Terapia combinada para moldular a resposta sexual humana |
US6037346A (en) * | 1997-10-28 | 2000-03-14 | Vivus, Inc. | Local administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
US6200591B1 (en) * | 1998-06-25 | 2001-03-13 | Anwar A. Hussain | Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction |
-
1999
- 1999-03-16 US US09/270,035 patent/US6087362A/en not_active Expired - Fee Related
-
2000
- 2000-03-14 IL IL14548700A patent/IL145487A0/xx unknown
- 2000-03-14 MX MXPA01009332A patent/MXPA01009332A/es active IP Right Grant
- 2000-03-14 CA CA002367605A patent/CA2367605A1/en not_active Abandoned
- 2000-03-14 WO PCT/US2000/006654 patent/WO2000054774A1/en active IP Right Grant
- 2000-03-14 NZ NZ514464A patent/NZ514464A/xx unknown
- 2000-03-14 DE DE60022021T patent/DE60022021T2/de not_active Expired - Fee Related
- 2000-03-14 ES ES00916324T patent/ES2244418T3/es not_active Expired - Lifetime
- 2000-03-14 CN CN00807580A patent/CN1350454A/zh active Pending
- 2000-03-14 BR BR0009016-6A patent/BR0009016A/pt not_active Application Discontinuation
- 2000-03-14 EP EP00916324A patent/EP1173178B1/en not_active Expired - Lifetime
- 2000-03-14 PL PL00350313A patent/PL350313A1/xx not_active Application Discontinuation
- 2000-03-14 PT PT00916324T patent/PT1173178E/pt unknown
- 2000-03-14 JP JP2000604850A patent/JP2002539163A/ja active Pending
- 2000-03-14 DK DK00916324T patent/DK1173178T3/da active
- 2000-03-14 AT AT00916324T patent/ATE302003T1/de not_active IP Right Cessation
- 2000-03-14 CZ CZ20013344A patent/CZ20013344A3/cs unknown
- 2000-03-14 HU HU0200549A patent/HUP0200549A3/hu unknown
- 2000-03-14 AU AU37445/00A patent/AU3744500A/en not_active Abandoned
-
2001
- 2001-09-17 NO NO20014519A patent/NO324511B1/no unknown
- 2001-09-26 ZA ZA200107920A patent/ZA200107920B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
EP1173178B1 (en) | 2005-08-17 |
EP1173178A1 (en) | 2002-01-23 |
MXPA01009332A (es) | 2002-06-21 |
NZ514464A (en) | 2004-01-30 |
CN1350454A (zh) | 2002-05-22 |
US6087362A (en) | 2000-07-11 |
HUP0200549A3 (en) | 2004-07-28 |
ATE302003T1 (de) | 2005-09-15 |
IL145487A0 (en) | 2002-06-30 |
NO20014519L (no) | 2001-10-25 |
WO2000054774A1 (en) | 2000-09-21 |
DK1173178T3 (da) | 2005-11-07 |
NO20014519D0 (no) | 2001-09-17 |
HUP0200549A2 (hu) | 2002-07-29 |
ES2244418T3 (es) | 2005-12-16 |
CZ20013344A3 (cs) | 2002-08-14 |
ZA200107920B (en) | 2003-03-26 |
NO324511B1 (no) | 2007-11-05 |
CA2367605A1 (en) | 2000-09-21 |
DE60022021T2 (de) | 2006-06-08 |
PL350313A1 (en) | 2002-12-02 |
AU3744500A (en) | 2000-10-04 |
EP1173178A4 (en) | 2002-09-04 |
JP2002539163A (ja) | 2002-11-19 |
PT1173178E (pt) | 2005-11-30 |
DE60022021D1 (de) | 2005-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0009016A (pt) | Composição de apomorfina e sildenafil | |
EA200300046A1 (ru) | Быстро увеличивающаяся в объеме композиция для удерживания и контролированного выделения терапевтических агентов в желудке и лекарственные формы, включающие композицию | |
JP2002522485A5 (pt) | ||
BRPI0510895A (pt) | formulação farmacêutica de 10-propargila-10-deazaaminopterina para tratamento de linfoma de célula t | |
BRPI0510862A (pt) | medicamento para tratar disfunção sexual em um paciente, medicamento para tratar disfunção erétil em um paciente, medicamento para diminuir os efeitos colaterais associados com os agentes terapêuticos para tratar a disfunção sexual em um paciente, método para fabricação de um medicamento para tratamento da disfunção sexual de um paciente responsivo marginalmente ao inibidor de pde5, e uso do peptìdeo ac-nle-ciclo (-asp-his-d-phe-arg-trp-lys) -0h na perparação de um medicamento | |
RU2006139819A (ru) | Применение симетикона для предрасположенных к запорам пациентов | |
HK1077215A1 (en) | A pharmaceutical composition for treatment of acute myocardial infarction | |
AR012731A1 (es) | Uso de un derivado de taxano para la preparacion de una composicion farmaceutica , uso de un agente mejorador de la biodicponibilidad de dicho derivado forma de dosificacion oral y conjunto afrmaceutico que lo comprende y metodo para formar a un agente activo biodisponible. | |
CO5251425A1 (es) | Metodo y composiciones para administrar taxanos oralmente a pacientes humanos | |
PT1027053E (pt) | Metodo de prevencao de nefrotoxicidade provocada por ciclosporinas e tacrolimus | |
AR023185A1 (es) | Tratamiento de cancer mejorado con temozolomida | |
JP2002540148A5 (pt) | ||
YU61598A (sh) | Tretmani bolesti uz korišćenje citokina | |
FI20011464A0 (fi) | Yhdistelmäterapia sydämen vajaatoiminnan hoitoon | |
Miller et al. | Successful treatment of actinomycosis with stilbamidine | |
CA2516458A1 (en) | Use of kahalalide compounds for the manufacture of a medicament for the treatment of psoriasis | |
AR029160A1 (es) | El uso del interferon-alfa pegilado para la preparacion de un medicamento para el tratamiento del carcinoma de celula renal, un kit y el uso del mismo | |
BE1002256A3 (fr) | Medicaments. | |
JP2001316293A5 (pt) | ||
HUP9901935A2 (hu) | Gyógyszerek és terápiás szerek és más glikozaminoglikánok (GAG) dózisainak célbajuttatására alkalmas dóziskészlet | |
MX2023008155A (es) | Regimenes de tratamiento con dosis fijas de tamibaroteno. | |
James | AZT twice-daily tablets approved: dosing concerns | |
BRPI0503488A (pt) | agente de tratamento para sìndrome de intestino irritável com diarréia predominante | |
RU2002129097A (ru) | Комбинированные терапии с использованием активности, повреждающей сосуды | |
CO5170404A1 (es) | Terapia para melanomas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFIRO O PEDIDO DE ACORDO COM O(S) ARTIGO(S) 8, 10(VIII), 11, 13, 24 E 25 DA LPI |
|
B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL. |